4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-22-027196
Options or other derivatives
- President, CMO acquired 610,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Huang Jane President, CMO | 2022-05-02 | Grant or award · Employee Stock Option (Right to Buy) | +460,000 | 460,000 | D | ||
| Huang Jane President, CMO | 2022-05-02 | Grant or award · Restricted Stock Unit | +150,000 | 150,000 | D | ||
Loading xslF345X03/doc4.xml…